feed,title,long_url,short_url
SeekingAlpha,Icosavax down 21% following top-line phase 1 data for RSV vaccine candidate,https://seekingalpha.com/news/3852662,
SeekingAlpha,"ICVX, MAPS, TCMD and AVAV among after hour movers",https://seekingalpha.com/news/3852663,
